X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (1245) 1245
Publication (102) 102
Book Chapter (12) 12
Book Review (9) 9
Dissertation (8) 8
Conference Proceeding (4) 4
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
3-nitropropionic acid (1149) 1149
animals (872) 872
neurosciences (661) 661
rats (546) 546
male (484) 484
index medicus (431) 431
oxidative stress (374) 374
huntington's disease (327) 327
huntingtons-disease (298) 298
nitro compounds (276) 276
mice (275) 275
disease models, animal (259) 259
humans (251) 251
rats, wistar (228) 228
biochemistry & molecular biology (207) 207
propionates - pharmacology (202) 202
brain (197) 197
corpus striatum - drug effects (190) 190
propionates - toxicity (184) 184
rats, sprague-dawley (184) 184
mitochondria (178) 178
striatum (169) 169
neurons - drug effects (167) 167
neurons (155) 155
mitochondria - drug effects (151) 151
pharmacology & pharmacy (149) 149
apoptosis (147) 147
parkinsons-disease (138) 138
corpus striatum - metabolism (136) 136
in-vivo (134) 134
female (131) 131
corpus striatum - pathology (130) 130
mitochondria - metabolism (129) 129
neurodegeneration (128) 128
neurons - metabolism (126) 126
neuroprotection (126) 126
neuroprotective agents - pharmacology (126) 126
succinate-dehydrogenase (126) 126
huntington disease - metabolism (124) 124
analysis (123) 123
neurotoxicity (123) 123
neurology (120) 120
nitro compounds - toxicity (120) 120
dose-response relationship, drug (119) 119
oxidative stress - drug effects (116) 116
neurodegenerative diseases (115) 115
cell-death (114) 114
huntington disease - pathology (112) 112
huntington's chorea (112) 112
toxin 3-nitropropionic acid (108) 108
cells, cultured (105) 105
motor activity - drug effects (102) 102
cell biology (100) 100
huntington disease - physiopathology (98) 98
quinolinic acid (98) 98
clinical neurology (95) 95
brain - drug effects (93) 93
brain - metabolism (92) 92
glutamate (91) 91
mitochondrial toxin (91) 91
excitotoxicity (88) 88
rat (87) 87
time factors (86) 86
antioxidants (83) 83
behavior, animal - drug effects (83) 83
huntington disease - chemically induced (83) 83
inhibition (83) 83
mitochondrial dysfunction (82) 82
nitro compounds - pharmacology (80) 80
neurons - pathology (79) 79
neurotoxins - toxicity (79) 79
lesions (76) 76
nervous system diseases (76) 76
huntington disease - genetics (75) 75
mice, transgenic (75) 75
propionates (75) 75
alzheimers-disease (74) 74
rat-brain (74) 74
basal ganglia (73) 73
brain - pathology (71) 71
immunohistochemistry (70) 70
dopamine (69) 69
energy-metabolism (69) 69
huntington disease - drug therapy (69) 69
mice, inbred c57bl (69) 69
in-vitro (67) 67
biomedicine (66) 66
transgenic mice (66) 66
cell death (64) 64
dopamine - metabolism (64) 64
lipid peroxidation - drug effects (64) 64
succinate dehydrogenase - antagonists & inhibitors (63) 63
parkinson's disease (62) 62
expression (61) 61
rodents (61) 61
apoptosis - drug effects (60) 60
mutant huntingtin (60) 60
huntington’s disease (59) 59
succinate dehydrogenase - metabolism (59) 59
3‐nitropropionic acid (58) 58
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1238) 1238
Spanish (9) 9
Chinese (6) 6
German (5) 5
French (3) 3
Croatian (1) 1
Portuguese (1) 1
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Neurochemical Research, ISSN 0364-3190, 10/2018, Volume 43, Issue 10, pp. 1938 - 1946
Journal Article
Journal Article
Food and Chemical Toxicology, ISSN 0278-6915, 11/2018, Volume 121, pp. 95 - 108
Journal Article
Journal Article
Biomedicine & Pharmacotherapy, ISSN 0753-3322, 2016, Volume 84, pp. 514 - 525
Graphical abstract 
Internal Medicine | Medical Education | Huntington’s disease | Apoptotic markers | Mitochondrial dysfunction | Histopathology | Chrysin | 3-Nitropropionic acid | Huntington's disease | MEDICINE, RESEARCH & EXPERIMENTAL | TOXIN | NEURONAL CELL-DEATH | FLAVONOIDS | MODEL | QUINOLINIC ACID | PROPOLIS | INHIBITION | PHARMACOLOGY & PHARMACY | HUNTINGTONS-DISEASE | BRAIN | MODULATION | Up-Regulation | Mitochondrial Swelling - drug effects | Rats, Wistar | Apoptosis - drug effects | Basal Ganglia - metabolism | Huntington Disease - psychology | Mitochondrial Diseases - metabolism | Motor Activity - drug effects | Male | Postural Balance - drug effects | Dose-Response Relationship, Drug | Mitochondrial Diseases - psychology | Proto-Oncogene Proteins c-bcl-2 - metabolism | Neuroprotective Agents - pharmacology | Time Factors | bcl-Associated Death Protein - metabolism | Behavior, Animal - drug effects | Flavonoids - pharmacology | Huntington Disease - physiopathology | bcl-2-Associated X Protein - genetics | Disease Models, Animal | Biomarkers - metabolism | bcl-Associated Death Protein - genetics | Mitochondrial Diseases - prevention & control | Huntington Disease - prevention & control | Down-Regulation | bcl-2-Associated X Protein - metabolism | Basal Ganglia - pathology | Maze Learning - drug effects | Huntington Disease - metabolism | Animals | Signal Transduction - drug effects | Nitro Compounds | Propionates | Oxidative Stress - drug effects | Mitochondrial Diseases - physiopathology | Nerve Degeneration | Proto-Oncogene Proteins c-bcl-2 - genetics | Basal Ganglia - drug effects | Genes | Apoptosis | Antioxidants | Flavonoids | Enzyme inhibitors | Flavones | RNA | Bioflavonoids | Genetic research | Superoxide
Journal Article
Neuroscience, ISSN 0306-4522, 2010, Volume 171, Issue 1, pp. 284 - 299
Abstract The present study has been designed to explore the protective effect of montelukast (leukotriene receptor antagonist) against intrastriatal quinolinic... 
Neurology | antioxidant | mitochondrial dysfunction | neurotoxicity | montelukast | oxidative stress | Montelukast | Oxidative stress | Neurotoxicity | Mitochondrial dysfunction | Antioxidant | HUNTINGTONS-DISEASE PATIENTS | NEURODEGENERATIVE DISORDERS | CYSTEINYL LEUKOTRIENE RECEPTOR-1 | ROS-DEPENDENT PATHWAY | NEUROTROPHIC FACTOR | 3-NITROPROPIONIC ACID | NEUROSCIENCES | CELL-DEATH | ANTAGONIST MONTELUKAST | ENERGY-METABOLISM | Brain Chemistry - drug effects | Neuroprotective Agents - therapeutic use | Tumor Necrosis Factor-alpha - metabolism | Rats, Wistar | Body Weight - drug effects | Motor Activity - drug effects | Nitrites - metabolism | Male | Quinolines - pharmacology | Brain - metabolism | Dose-Response Relationship, Drug | Tetrazolium Salts | Neuroprotective Agents - pharmacology | Neurotoxicity Syndromes - pathology | Brain - ultrastructure | Lipid Peroxidation - drug effects | Thiazoles | Behavior, Animal - drug effects | Acetates - therapeutic use | Quinolinic Acid - toxicity | Superoxide Dismutase - metabolism | Disease Models, Animal | Drug Administration Schedule | Rats | Neurotoxicity Syndromes - prevention & control | Mitochondria - metabolism | Mitochondria - drug effects | Brain - drug effects | Catalase - metabolism | Gene Expression Regulation - drug effects | Malonates - toxicity | Neurotoxicity Syndromes - etiology | Animals | Analysis of Variance | Acetates - pharmacology | Quinolines - therapeutic use | Index Medicus
Journal Article
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, ISSN 0027-8424, 08/2002, Volume 99, Issue 16, pp. 10671 - 10676
Huntington's disease (HD) is an untreatable neurological disorder caused by selective and progressive degeneration of the caudate nucleus and putamen of the... 
POLYGLUTAMINE TRACT | REPEAT LENGTH | URSODEOXYCHOLIC ACID | DNA FRAGMENTATION | INDUCED APOPTOSIS | MULTIDISCIPLINARY SCIENCES | MOUSE MODEL | 3-NITROPROPIONIC ACID | CYTOCHROME-C RELEASE | ENERGY-METABOLISM | CELL-DEATH
Journal Article
Neurotoxicology and Teratology, ISSN 0892-0362, 2011, Volume 33, Issue 5, pp. 538 - 547
Abstract Kynurenic acid (KYNA) is an endogenous metabolite of the kynurenine pathway for tryptophan degradation and an antagonist of both N-methyl- d... 
Medical Education | Emergency | Lipid peroxidation | Oxidative stress | Kynurenic acid | Iron sulfate | Antioxidant defense | ROS formation | MITOCHONDRIAL TOXIN | 3-NITROPROPIONIC ACID | STRIATAL VULNERABILITY | HIPPOCAMPAL-NEURONS | NEUROSCIENCES | HYDROXYL RADICALS | QUINOLINIC ACID | ACETYLCHOLINE-RECEPTORS | IN-VIVO | HYDROGEN-PEROXIDE | TOXICOLOGY | INDUCED NEUROTOXICITY | Free Radical Scavengers - pharmacology | Propionates - pharmacology | Reactive Oxygen Species - metabolism | Rats, Wistar | Cerebellum - drug effects | Male | Corpus Striatum - metabolism | Propionates - antagonists & inhibitors | Prosencephalon - drug effects | Dose-Response Relationship, Drug | Hydroxides - metabolism | Ferrous Compounds - pharmacology | Lipid Peroxidation - drug effects | Nitro Compounds - pharmacology | Kynurenic Acid - pharmacology | Prosencephalon - metabolism | Ferrous Compounds - antagonists & inhibitors | Microinjections | Oocytes - metabolism | Cerebellum - metabolism | Xenopus laevis | Cells, Cultured | Rats | Antioxidants - pharmacology | Animals | Antioxidants - administration & dosage | Corpus Striatum - drug effects | Oxidative Stress - drug effects | Kynurenic Acid - administration & dosage | Nitro Compounds - antagonists & inhibitors | Antioxidants | Tryptophan | Evaluation | Methyl aspartate | Analysis | Free radicals | N-Methyl-D-aspartic acid receptors | Glutamic acid receptors | Degradation | Controlled conditions | Anions | Metabolites | Hydroxyl radicals | superoxide anions
Journal Article
Acta Histochemica, ISSN 0065-1281, 10/2017, Volume 119, Issue 8, pp. 795 - 803
Journal Article
Neurotoxicity Research, ISSN 1029-8428, 8/2014, Volume 26, Issue 2, pp. 130 - 151
Journal Article